Depression, Sleep Health & Sociodemographic Correlates in a Nationwide Survey: Implications for Depression Treatment During the COVID-19
Maurice Junior Chery,Amrit Baral,LaShae D Rolle,Alireza Abdshah,Maritza J Bernard,Laxmi Poudel,Laura Francois,Deborah L Jones,Girardin Jean-Louis,Judite Blanc
DOI: https://doi.org/10.2147/nss.s434148
2024-01-13
Nature and Science of Sleep
Abstract:Maurice Junior Chery, 1 Amrit Baral, 1 LaShae D Rolle, 1 Alireza Abdshah, 1 Maritza J Bernard, 2 Laxmi Poudel, 3 Laura Francois, 1 Deborah L Jones, 4 Girardin Jean-Louis, 4 Judite Blanc 4 1 Department of Public Health Sciences, the University of Miami Miller School of Medicine, Miami, Florida, USA; 2 Anne Bates Leach Eye Hospital at Bascom Palmer Eye Institute, the University of Miami Miller School of Medicine, Miami, FL, USA; 3 South Florida Integrative Medicine, Miami, FL, USA; 4 Department of Psychiatry and Behavioral Sciences, University of Miami Miller School of Medicine, Miami, FL, USA Correspondence: Judite Blanc, Department of Public Health Sciences, the University of Miami Miller School of Medicine, 1120 NW 14th St, Room 1448, Miami, FL, 33136, USA, Tel +1 954 471 0739, Email Maurice Junior Chery, Department of Public Health Sciences, the University of Miami Miller School of Medicine, 1120 NW 14th St, Room 1448, Miami, FL, 33136, USA, Tel +1 343 204 7128, Email Purpose: The COVID-19 pandemic has had a profound impact on mental health worldwide, with depression and sleep problems among the most common issues experienced by many individuals. Depression can lead to sleep problems, which can increase the risk of developing depressive symptoms. However, it is unclear which United States (US) sub-population was most affected by depression and sleep problems during the pandemic. Methods: We conducted a secondary analysis using self-reported data from the 2021 National Health Interview Survey (NHIS), focusing on adults aged 18 years and above (n=29,763). We utilized self-reported responses to questions about prescription medication and frequency of depressive feelings to determine participants' depression status. Appropriate weights were applied to account for the sampling design of the surveys. Our analysis involved descriptive statistics and chi-squared tests to compare sociodemographic, clinical, behavioral, and sleep-related characteristics between US adults with and without depression. Additionally, logistic regression was used to examine the associations between sleep duration, sleep quality and depression. Results: The overall prevalence of depression in our sample was 44.4%. It were higher in certain demographic groups, including younger adults (18– 39 years, 47.7%), non-Hispanic whites (47.9%), females (50.1%), those at the lower income bracket (52.2%), those with no college or degree (48.7%) uninsured individuals (45.2%), and those reporting poor general health (71.9%). Individuals with depression had a 12% increased odds of experiencing short sleep (aOR: 1.12, 95% CI:1.04– 1.20, p< 0.001), 34% increased odds of experiencing long sleep (aOR: 1.34, 95% CI: 1.20– 1.50, p < 0.001) and more than 2.5 fold increased odds of reporting poor sleep quality (aOR:2.57, 95% CI: 2.40– 2.78; p< 0.0001). In the multivariate analysis, all variables (sex, race/ethnicity, education, health insurance coverage, marital status, general health status and use of sleep medications, smoking and alcohol use status) were significantly predictors of poor sleep quality, with the exceptions of age and family income. Conclusion: The findings emphasize the need to address sleep health in treating depression, especially during times of public health crises. Keywords: depression, sleep health, sleep hygiene, sleep disparities, sleep quality, COVID-19 The COVID-19 pandemic, declared by the World Health Organization in March 2020, has profoundly impacted global health, extending beyond the direct effects of the SARS-CoV-2 virus. 1 In the US, the scenario during the NHIS 2020 was marked by escalating case numbers, stretching healthcare systems and leading to implementation of varying degrees of restrictions and lockdowns across different states to curb the virus spread. 2,3 According to the Centers for Disease Control and Prevention (CDC), by the end of 2020, the US had reported over 20 million cases and more than 350,000 deaths attributed to COVID-19. 4 To adapt to the evolving conditions and ensure the safety of both respondents and interviewers, the NHIS adjusted its data collection strategy, transitioning from in-person interviews to an online format, an adaptation that was pivotal in the continuity of the survey amidst the pandemic conditions. 5 While the immediate physical health impacts have been widely studied, the pandemic's mental health consequences, specifically depression and sleep outcomes, are becoming increasingly apparent. 6 Depression is a pervasive global health issue, affecting over 5% of adults and experiencing a marked increase i -Abstract Truncated-
neurosciences,clinical neurology